Drug supply in Canada : a multi-stakeholder responsibility / Chair: Joy Smith, M.P. : XC62-1/411-02E-PDF
During meetings on 27 and 29 March, as well as 3 April 2012, the Committee heard from Health Canada officials, representatives of the pharmaceutical industry, healthcare professionals, pharmaceutical wholesalers and bulk purchasers, and patient advocates. This report outlines the role played by these stakeholders, summarizes the concerns that were expressed and offers recommendations that may mitigate future disruptions in the drug supply.
Lien permanent pour cette publication :
publications.gc.ca/pub?id=9.574624&sl=1
| Ministère/Organisme | Canada. Parliament. House of Commons. Standing Committee on Health. |
|---|---|
| Titre | Drug supply in Canada : a multi-stakeholder responsibility / Chair: Joy Smith, M.P. |
| Titre de la série | Report of the Standing Committee on Health41st Parliament, first session, ninth report |
| Type de publication | Série - Voir l'enregistrement principal |
| Langue | [Anglais] |
| Autres langues publiées | [Français] |
| Format | Électronique |
| Document électronique | |
| Autres formats offerts | Papier-[Anglais | Français] |
| Note(s) | Original published on: 2012/06/08; published on: 2012/11/16. |
| Information sur la publication | Ottawa - Ontario : House of Commons. |
| Description | 44p.figs., references |
| Numéro de catalogue |
|
| Descripteurs | Drugs Pharmaceutical industry Supply chain management |